Literature DB >> 15193309

Metabolic networks: enzyme function and metabolite structure.

Vassily Hatzimanikatis1, Chunhui Li, Justin A Ionita, Linda J Broadbelt.   

Abstract

Metabolism is one of the most complex cellular processes. Connections between biochemical reactions via substrate and product metabolites create complex metabolic networks that may be analyzed using network theory, stoichiometric analysis, and information on protein structure/function and metabolite properties. These frameworks take into consideration different aspects of enzyme chemistry, enzyme structure and metabolite structure, and demonstrate the impact of metabolic biochemistry on the systemic properties of metabolism. The integration of these approaches and the systematic classification of enzyme function and the chemical structure of metabolites will enhance our understanding of metabolism, and could improve our ability to predict enzyme function and novel metabolic pathways.

Mesh:

Substances:

Year:  2004        PMID: 15193309     DOI: 10.1016/j.sbi.2004.04.004

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  21 in total

1.  Functional cartography of complex metabolic networks.

Authors:  Roger Guimerà; Luís A Nunes Amaral
Journal:  Nature       Date:  2005-02-24       Impact factor: 49.962

2.  When individual behaviour matters: homogeneous and network models in epidemiology.

Authors:  Shweta Bansal; Bryan T Grenfell; Lauren Ancel Meyers
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

3.  Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.

Authors:  Jeffrey K Yao; George G Dougherty; Ravinder D Reddy; Matcheri S Keshavan; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

4.  Deep learning enables high-quality and high-throughput prediction of enzyme commission numbers.

Authors:  Jae Yong Ryu; Hyun Uk Kim; Sang Yup Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-20       Impact factor: 11.205

5.  Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.

Authors:  HuaLin Cai; Xiang Zhou; George G Dougherty; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Matcheri Keshavan; Jeffrey K Yao
Journal:  Psychoneuroendocrinology       Date:  2018-02-07       Impact factor: 4.905

6.  In silico feasibility of novel biodegradation pathways for 1,2,4-trichlorobenzene.

Authors:  Stacey D Finley; Linda J Broadbelt; Vassily Hatzimanikatis
Journal:  BMC Syst Biol       Date:  2010-02-02

7.  Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.

Authors:  J K Yao; G G Dougherty; R D Reddy; M S Keshavan; D M Montrose; W R Matson; S Rozen; R R Krishnan; J McEvoy; R Kaddurah-Daouk
Journal:  Mol Psychiatry       Date:  2009-04-28       Impact factor: 15.992

8.  Computational framework for predictive biodegradation.

Authors:  Stacey D Finley; Linda J Broadbelt; Vassily Hatzimanikatis
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

9.  Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity.

Authors:  Q K Beg; A Vazquez; J Ernst; M A de Menezes; Z Bar-Joseph; A-L Barabási; Z N Oltvai
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

10.  Population-based case-control study revealed metabolomic biomarkers of suboptimal health status in Chinese population-potential utility for innovative approach by predictive, preventive, and personalized medicine.

Authors:  Hao Wang; Qiuyue Tian; Jie Zhang; Hongqi Liu; Xiaoyu Zhang; Weijie Cao; Jinxia Zhang; Enoch Odame Anto; Xingang Li; Xueqing Wang; Di Liu; Yulu Zheng; Zheng Guo; Lijuan Wu; Manshu Song; Youxin Wang; Wei Wang
Journal:  EPMA J       Date:  2020-03-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.